Laboratorios Luar

Laboratorios Luar is a Cuban pharmaceutical and biotechnology company operating as a subsidiary of the state-owned BioCubaFarma group. Based in Havana, the company is dedicated to the research, development, and manufacturing of innovative therapeutic products, including monoclonal antibodies and natural medicines. It is notably involved in the production and clinical evaluation of Itolizumab, an anti-CD6 monoclonal antibody used for autoimmune conditions and inflammatory responses in COVID-19 patients. The company also focuses on natural health solutions, such as the turmeric-based product Curmeric, which is utilized for its antioxidant and anti-inflammatory properties. Laboratorios Luar serves as a key manufacturing hub within Cuba's scientific pole, supporting both domestic healthcare needs and international collaborations.